Lynx1 Capital Management as of June 30, 2024
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 17 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Merus N V (MRUS) | 25.9 | $71M | 1.2M | 59.17 | |
Stoke Therapeutics (STOK) | 25.4 | $70M | 5.2M | 13.51 | |
Gh Research Ordinary Shares (GHRS) | 16.8 | $46M | 4.0M | 11.66 | |
C4 Therapeutics Com Stk (CCCC) | 11.5 | $32M | 6.9M | 4.62 | |
Tscan Therapeutics (TCRX) | 11.1 | $31M | 5.2M | 5.85 | |
Cullinan Oncology (CGEM) | 2.4 | $6.6M | 377k | 17.44 | |
Allogene Therapeutics (ALLO) | 1.9 | $5.2M | 2.2M | 2.33 | |
Longboard Pharmaceuticals In (LBPH) | 1.6 | $4.5M | 167k | 27.03 | |
Passage Bio (PASG) | 1.5 | $4.0M | 5.1M | 0.79 | |
Cabaletta Bio (CABA) | 1.3 | $3.7M | 492k | 7.48 | |
Ibio Con New (IBIO) | 0.2 | $508k | 241k | 2.11 | |
Bionomics Ads (BNOX) | 0.2 | $460k | 600k | 0.77 | |
Pieris Pharmaceuticals Com New (PIRS) | 0.2 | $427k | 44k | 9.81 | |
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.1 | $177k | 9.5k | 18.67 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $157k | 17k | 9.03 | |
Korro Bio (KRRO) | 0.0 | $129k | 3.8k | 33.87 | |
Vyne Therapeutics (VYNE) | 0.0 | $32k | 16k | 1.97 |